Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15983299 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia
Condition: Diabetes Mellitus
Interventions: Drug: Pioglitazone;   Drug: Rosiglitazone

Indicates status has not been verified in more than two years